The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ibrutinib dose modifications for management of cardiac adverse events in patients with B-cell malignancies: Pooled analysis of 10 clinical trials.
 
Deborah Marie Stephens
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; BeiGene; BMS; Celgene; CSL Behring; Genentech; Lilly; TG Therapeutics
Research Funding - Acerta Pharma; ArQule; Iovance Biotherapeutics; Juno Therapeutics; Karyopharm Therapeutics; MingSight; Newave Pharmaceutical; Newave Pharmaceutical (Inst); Novartis
 
Jennifer R. Brown
Consulting or Advisory Role - Abbvie; Acerta/Astra-Zeneca; BeiGene; Bristol-Myers Squibb/Celgene/Juno; Catapult Therapeutics; Genentech/Roche; HUTCHMED; iOnctura; Janssen; Lilly; MEI Pharma; MorphoSys; Novartis; Pharmacyclics
Research Funding - BeiGene (Inst); Gilead Sciences (Inst); Loxo/Lilly (Inst); MEI Pharma (Inst); Secura Bio (Inst); Sun Pharma (Inst); TG Therapeutics (Inst)
 
Shuo Ma
Honoraria - Abbvie; AstraZeneca; Genentech; Gilead Sciences; Janssen; Kite, a Gilead Company; Pharmacyclics; Verastem
Consulting or Advisory Role - Abbvie; AstraZeneca; Genentech; Gilead Sciences; Janssen; Kite, a Gilead Company; Pharmacyclics; Verastem
Speakers' Bureau - AstraZeneca; BeiGene; Janssen; Pharmacyclics
Research Funding - Abbvie (Inst); AstraZeneca (Inst); BeiGene (Inst); Janssen (Inst); Juno Therapeutics (Inst); Loxo (Inst); Novartis (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
 
Michael Wang
Honoraria - Abbvie; Acerta Pharma; AstraZeneca; Bantam Pharmaceutical; BeiGene; Bioinvent; Breast-Gynecological International Cancer Society; Bristol Myers Squibb Foundation; CAHON; Dava Oncology; Eastern Virginia Medical School; Genmab; IDEOlogy Health; Janssen Research & Development; Kite, a Gilead company; Leukemia and Lymphoma Society; MD Education; Medscape; Meeting Minds Experts; Merck; Moffit Cancer Center; Nurix; OncLive/MJH Life Sciences; Oncology Specialty Group; Pharmacyclics/Janssen; Physicans' Education Resource; Practice Point Communications; Studio ER Congressi
Consulting or Advisory Role - Abbvie; Acerta Pharma; ADC Therapeutics; Amphista Therapeutics; AstraZeneca; Be Biopharma; BeiGene; Bioinvent; Deciphera; DTRM; Genentech; Innocare; Janssen Research & Development; Kite, a Gilead company; Leukemia and Lymphoma Society; Lilly; Merck; Milken Institute; Miltenyi Biomedicine; Oncternal Therapeutics; Parexel; Pepromene; Pepromene; Pharmacyclics/Janssen; VelosBio
Research Funding - Acerta Pharma; AstraZeneca; BeiGene; Bioinvent; Celgene; Genentech; Genmab; Innocare; Janssen Research & Development; Juno Therapeutics; Kite, a Gilead company; Lilly; Loxo; Molecular Templates; Oncternal Therapeutics; Pharmacyclics; VelosBio; Vincerx Pharma
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Dava Oncology; Kite, a Gilead company; Physicans' Education Resource
 
Carolina D. Moreno
Consulting or Advisory Role - Abbvie; Ascentage Pharma; AstraZeneca; Janssen
Speakers' Bureau - Janssen
Research Funding - Abbvie; Janssen
 
Tadeusz Robak
Honoraria - AstraZeneca; BeiGene; Janssen
Consulting or Advisory Role - AstraZeneca; BeiGene; Janssen Oncology
Research Funding - AstraZeneca; BeiGene; Janssen
 
Don A. Stevens
No Relationships to Disclose
 
Xin (Shane) Li (Lee)
Employment - Abbvie/Pharmacyclics; Regeneron
Stock and Other Ownership Interests - Abbvie/Pharmacyclics
 
Chadi Saifan
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Emily Hsu
Employment - Pharmacyclics
Stock and Other Ownership Interests - Abbvie
 
Sima Patel
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Jan Andreas Burger
Honoraria - Gilead Sciences; Janssen; Novartis; Pharmacyclics; TG Therapeutics
Consulting or Advisory Role - BeiGene; Gilead Sciences; Janssen; Pharmacyclics; TG Therapeutics
Speakers' Bureau - BeiGene; Gilead Sciences; Janssen; Pharmacyclics; TG Therapeutics
Research Funding - AstraZeneca; BeiGene; Pharmacyclics
Travel, Accommodations, Expenses - Gilead Sciences; Janssen; Novartis; Pharmacyclics; TG Therapeutics